Abstract and Keywords
This article reviews, first, the rationale for price regulation of on-patent pharmaceuticals and then models of optimal regulatory structure. It then describes the main regulatory prototypes for on-patent drugs and the empirical evidence on their effects. This is followed by a review of regulatory and reimbursement regimes for generics and evidence of their effects. Finally, international regulation of promotion is addressed. The concluding section reviews major unanswered research questions.
Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.